Which patents cover Epiduo (and who owns them at Galderma)?
Epiduo is a brand name for a topical acne medicine combination developed and marketed by Galderma. The patent landscape typically includes multiple layers: patents covering specific formulations and concentrations, device/packaging or process patents, and sometimes broader composition-of-matter filings that protect active ingredients or their combinations.
When do Galderma’s Epiduo patents expire?
Patent expiry depends on the exact patent family, country, and whether you’re looking at the first filing date, regulatory/extension periods, or any exclusivity that applies in that jurisdiction. Without the specific market (e.g., EU vs. UK vs. US) and the exact product listing, the exact expiry date cannot be stated reliably from the information provided.
How to check the exact Galderma Epiduo patent numbers (by country)?
A practical way to pin down the correct patent(s) is to search by:
- product name (Epiduo)
- active ingredients (the combination used in Epiduo)
- company (Galderma)
- target country (EP/DE/FR, UK, US, etc.)
DrugPatentWatch.com is commonly used for this kind of tracking and can help identify relevant patent identifiers and expiry dates when you specify the jurisdiction and product entry: DrugPatentWatch - Epiduo / Galderma
What if you mean “Epiduo Forte” or a specific Galderma skin product?
Galderma’s acne portfolio includes multiple topical combinations (for example, “Epiduo” vs “Epiduo Forte”). Patent coverage and expiry can differ between strengths/formulations even when the product names sound similar. To avoid mixing them, it helps to confirm:
- the exact product name (Epiduo vs Epiduo Forte)
- the country you care about
- the active strengths listed on-pack
Is there a risk of mix-ups with “generic” or “substitute” versions?
Topical combination acne products can be marketed as generics or “equivalents” depending on regulatory status, but that doesn’t automatically mean patents are fully expired. Patent protection (and regulatory exclusivity) can restrict launches of direct product copies or specific formulations, even if the active ingredients are available.
Quick clarification so I can give exact expiry/patent details
Which one do you need?
1) Country (EU, UK, US, or another)?
2) Exact product (Epiduo or Epiduo Forte, and strength)?
3) Do you want Galderma’s patents (brand owner) or patents for the active ingredients?
Reply with those details and I can narrow the answer to the specific Galderma patent(s) and the likely expiry timeline.
Sources